Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma

R. Böni, Alexander Vortmeyer, S. Huang, G. Burg, G. Hofbauer, Z. Zhuang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

During the initiation and progression of malignant melanoma a series of genetic events accumulate, including alterations of chromosome 11q. Recently, an important tumour suppressor gene, the multiple endocrine neoplasia type 1 (MEN1) gene, has been mapped on 11q13 and has been cloned. To assess whether the MEN1 region is involved in tumour initiation and progression, we analysed 23 primary cutaneous melanomas and 17 metastases for loss of heterozygosity (LOH) using two informative polymorphic markers closely linked to the MEN1 gene (PYGM and D11S449). To search for mutations within the gene, single- strand conformation polymorphism (SSCP) analysis was performed using 13 primer sets with designed intronic sequences to amplify the MEN1 coding sequence exons 2 to 10. None of the cases showed LOH at the MEN1 gene locus. By SSCP analysis, no aberrant bands were identified on exons 3 to 10. Analysis of exon 2 revealed the presence of aberrant bands in two of the analysed melanomas. Sequencing analysis revealed a genetic polymorphism at S145S (AGC→ACT) in both sections. None of the cases analysed showed MEN1 gene mutations. This study represents the first genetic analysis of the MEN1 gene in sporadic melanomas. Our data demonstrate no evidence of deletion or mutation of the MEN1 gene in primary or metastatic melanoma. Therefore, MEN1 gene alterations appear not to be associated with tumorigenesis of malignant melanoma. The MEN1 gene appears to be a highly specific tumour suppressor gene only involving tumours within the spectrum of MEN1 disease.

Original languageEnglish (US)
Pages (from-to)249-252
Number of pages4
JournalMelanoma Research
Volume9
Issue number3
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

Multiple Endocrine Neoplasia Type 1
Tumor Suppressor Genes
Melanoma
Mutation
Genes
Exons
Loss of Heterozygosity
Sequence Deletion
Genetic Polymorphisms
Neoplasms
Carcinogenesis
Chromosomes

Keywords

  • Genetic mutation
  • Malignant melanoma
  • MEN1
  • Tumour suppressor gene

ASJC Scopus subject areas

  • Oncology
  • Dermatology
  • Cancer Research

Cite this

Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma. / Böni, R.; Vortmeyer, Alexander; Huang, S.; Burg, G.; Hofbauer, G.; Zhuang, Z.

In: Melanoma Research, Vol. 9, No. 3, 01.01.1999, p. 249-252.

Research output: Contribution to journalArticle

Böni, R. ; Vortmeyer, Alexander ; Huang, S. ; Burg, G. ; Hofbauer, G. ; Zhuang, Z. / Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma. In: Melanoma Research. 1999 ; Vol. 9, No. 3. pp. 249-252.
@article{37b2934d224c4600819ed6c9bd1a063c,
title = "Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma",
abstract = "During the initiation and progression of malignant melanoma a series of genetic events accumulate, including alterations of chromosome 11q. Recently, an important tumour suppressor gene, the multiple endocrine neoplasia type 1 (MEN1) gene, has been mapped on 11q13 and has been cloned. To assess whether the MEN1 region is involved in tumour initiation and progression, we analysed 23 primary cutaneous melanomas and 17 metastases for loss of heterozygosity (LOH) using two informative polymorphic markers closely linked to the MEN1 gene (PYGM and D11S449). To search for mutations within the gene, single- strand conformation polymorphism (SSCP) analysis was performed using 13 primer sets with designed intronic sequences to amplify the MEN1 coding sequence exons 2 to 10. None of the cases showed LOH at the MEN1 gene locus. By SSCP analysis, no aberrant bands were identified on exons 3 to 10. Analysis of exon 2 revealed the presence of aberrant bands in two of the analysed melanomas. Sequencing analysis revealed a genetic polymorphism at S145S (AGC→ACT) in both sections. None of the cases analysed showed MEN1 gene mutations. This study represents the first genetic analysis of the MEN1 gene in sporadic melanomas. Our data demonstrate no evidence of deletion or mutation of the MEN1 gene in primary or metastatic melanoma. Therefore, MEN1 gene alterations appear not to be associated with tumorigenesis of malignant melanoma. The MEN1 gene appears to be a highly specific tumour suppressor gene only involving tumours within the spectrum of MEN1 disease.",
keywords = "Genetic mutation, Malignant melanoma, MEN1, Tumour suppressor gene",
author = "R. B{\"o}ni and Alexander Vortmeyer and S. Huang and G. Burg and G. Hofbauer and Z. Zhuang",
year = "1999",
month = "1",
day = "1",
doi = "10.1097/00008390-199906000-00006",
language = "English (US)",
volume = "9",
pages = "249--252",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma

AU - Böni, R.

AU - Vortmeyer, Alexander

AU - Huang, S.

AU - Burg, G.

AU - Hofbauer, G.

AU - Zhuang, Z.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - During the initiation and progression of malignant melanoma a series of genetic events accumulate, including alterations of chromosome 11q. Recently, an important tumour suppressor gene, the multiple endocrine neoplasia type 1 (MEN1) gene, has been mapped on 11q13 and has been cloned. To assess whether the MEN1 region is involved in tumour initiation and progression, we analysed 23 primary cutaneous melanomas and 17 metastases for loss of heterozygosity (LOH) using two informative polymorphic markers closely linked to the MEN1 gene (PYGM and D11S449). To search for mutations within the gene, single- strand conformation polymorphism (SSCP) analysis was performed using 13 primer sets with designed intronic sequences to amplify the MEN1 coding sequence exons 2 to 10. None of the cases showed LOH at the MEN1 gene locus. By SSCP analysis, no aberrant bands were identified on exons 3 to 10. Analysis of exon 2 revealed the presence of aberrant bands in two of the analysed melanomas. Sequencing analysis revealed a genetic polymorphism at S145S (AGC→ACT) in both sections. None of the cases analysed showed MEN1 gene mutations. This study represents the first genetic analysis of the MEN1 gene in sporadic melanomas. Our data demonstrate no evidence of deletion or mutation of the MEN1 gene in primary or metastatic melanoma. Therefore, MEN1 gene alterations appear not to be associated with tumorigenesis of malignant melanoma. The MEN1 gene appears to be a highly specific tumour suppressor gene only involving tumours within the spectrum of MEN1 disease.

AB - During the initiation and progression of malignant melanoma a series of genetic events accumulate, including alterations of chromosome 11q. Recently, an important tumour suppressor gene, the multiple endocrine neoplasia type 1 (MEN1) gene, has been mapped on 11q13 and has been cloned. To assess whether the MEN1 region is involved in tumour initiation and progression, we analysed 23 primary cutaneous melanomas and 17 metastases for loss of heterozygosity (LOH) using two informative polymorphic markers closely linked to the MEN1 gene (PYGM and D11S449). To search for mutations within the gene, single- strand conformation polymorphism (SSCP) analysis was performed using 13 primer sets with designed intronic sequences to amplify the MEN1 coding sequence exons 2 to 10. None of the cases showed LOH at the MEN1 gene locus. By SSCP analysis, no aberrant bands were identified on exons 3 to 10. Analysis of exon 2 revealed the presence of aberrant bands in two of the analysed melanomas. Sequencing analysis revealed a genetic polymorphism at S145S (AGC→ACT) in both sections. None of the cases analysed showed MEN1 gene mutations. This study represents the first genetic analysis of the MEN1 gene in sporadic melanomas. Our data demonstrate no evidence of deletion or mutation of the MEN1 gene in primary or metastatic melanoma. Therefore, MEN1 gene alterations appear not to be associated with tumorigenesis of malignant melanoma. The MEN1 gene appears to be a highly specific tumour suppressor gene only involving tumours within the spectrum of MEN1 disease.

KW - Genetic mutation

KW - Malignant melanoma

KW - MEN1

KW - Tumour suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0032864006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032864006&partnerID=8YFLogxK

U2 - 10.1097/00008390-199906000-00006

DO - 10.1097/00008390-199906000-00006

M3 - Article

C2 - 10465580

AN - SCOPUS:0032864006

VL - 9

SP - 249

EP - 252

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 3

ER -